An increasing number of studies indicate that the sustained neuroinflammatory process involving microglia and astrocytes activation significantly contributes to the progression of tau pathology and neurodegenerative diseases, emphasizing the significance of neuroinflammation as a therapeutic target for neurodegenerative diseases (Laurent et al., 2018). Here, MAPT is linked to neurodegenerative disease.